Biotech News

Celldex to Present at Upcoming Investor Conferences

Celldex Therapeutics (CLDX)Celldex TherapeuticsConference / presentation

Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences:

Guggenheim Emerging Outlook: Biotech Summit 2026 on Wednesday, February 11 at 3:30 pm ET

TD Cowen 46th Annual Health Care Conference on Wednesday, March 4 at 9:10 am ET

Leerink Global Healthcare Conference on Tuesday, March 10 at 3:40 pm ET

Live webcasts of the presentations will be available on the " Events & Presentations " page of the "Investors" section of the Celldex website. Replays will be available for 90 days following the event.

About Celldex Celldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visit www.celldex.com .

Company Contact Sarah Cavanaugh Senior Vice President, Corporate Affairs & Administration (508) 864-8337 [email protected]

Patrick Till Meru Advisors (484) 788-8560 [email protected]

Related news

Celldex Therapeutics

Mast Cell-Targeted Immunology Company Celldex Therapeutics is developing barzolvolimab, a KIT-targeting antibody for mast cell-driven diseases. Because KIT signaling is central to mast cell survival and function, the therapy is intended to provide deeper disease modification than symptom-focused treatment alone. Barzolvolimab in...

Recent company news

Stock data

Close
40.38 USD
Market cap
2.27B USD
Exchange
NASDAQ
Sector
Biopharma
Location
United States